Viewing Study NCT02500550


Ignite Creation Date: 2025-12-24 @ 4:46 PM
Ignite Modification Date: 2026-01-04 @ 2:53 AM
Study NCT ID: NCT02500550
Status: COMPLETED
Last Update Posted: 2021-05-18
First Post: 2015-07-14
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety and Efficacy of Two Doses of ATIR101, a T-lymphocyte Enriched Leukocyte Preparation Depleted of Host Alloreactive T-cells, in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical Donor
Sponsor: Kiadis Pharma
Organization: